A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia
Naoko Yamamoto(Disco (japan)), Tetsuo Nishikawa(Yokohama Rosai Hospital), Hitoshi Arioka(Yokohama Rosai Hospital), Rei Hirose(Yokohama Rosai Hospital), Sho Katsuragawa(Yokohama Rosai Hospital), Yoshitomo Hoshino(University of Tokyo Hospital), Jun Saitou(Yokohama Rosai Hospital), Tomoko Takiguchi(Chiba University), Takashi Sunouchi(University of Tokyo Hospital), Hiroko Yukawa(Yokohama Rosai Hospital), Yuya Tsurutani(Yokohama Rosai Hospital), Haremaru Kubo(Ohta Nishinouchi Hospital), Masahiro Ichikawa(Fukushima Medical University)
Cited by 22
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes
|Genome Research|2005|506
Human protein factory for converting the transcriptome into an in vitro–expressed proteome
|Nature Methods|2008|269
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|The Lancet. Gastroenterology & hepatology|2017|200
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma
|Annals of Allergy Asthma & Immunology|2000|155